Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients
- PMID: 7609279
- DOI: 10.1177/0148607195019002137
Adjuvant recombinant human growth hormone normalizes plasma amino acids in parenterally fed trauma patients
Abstract
Background: The addition of an anabolic stimulant during intensive nutrition therapy in trauma patients seems to be a reasonable adjuvant for minimizing muscle-mass erosion. The plasma free amino acid pattern is the mirror of the net amino acid metabolism, and we have measured the progressive changes resulting from recombinant human growth hormone therapy in trauma victims during nutritional repletion in the early catabolic flow phase of injury.
Methods: In 20 severely injured (injury severity scale = 31 +/- 2), highly catabolic, and hypermetabolic adult multiple-trauma patients, we have measured the fasting (day 0) plasma amino acid levels (48 to 60 hours after injury before starting the nutrition therapy) and their progressive changes during 7 days of IV nutrition support (total parenteral nutrition, 1.1 x resting energy expenditure calories, 250 mg of nitrogen per kilogram per day) with or without adjuvant recombinant human growth hormone. Group H (n = 10) randomly received daily recombinant human growth hormone (0.15 mg of Somatropin per kilogram per day) and Group C (n = 10) received the vehicle of infusion.
Results: Hypoaminoacidemia of trauma is normalized by infusion of recombinant human growth hormone, which indicates its anabolic nature, and this is confirmed in the cumulative nitrogen balance (-281 +/- 139 mg of nitrogen per kilogram per 7 days compared with -809 +/- 151 mg of nitrogen per kilogram per 7 days without recombinant human growth hormone; p < or = .005). This improved nitrogen retention is also reflected in the significantly low blood urea nitrogen levels in the recombinant human growth hormone group, which represents the efficient utilization of the infused amino acids for synthesis of proteins. Elevated plasma insulin-like growth factor-1 levels in Group H compared with those in Group C may also account for this altered amino acid metabolism.
Conclusions: Recombinant human growth hormone treatment in combination with conventional total parenteral nutrition in the immediate posttraumatic period improved nitrogen metabolism and normalized the plasma free amino acid levels.
Similar articles
-
Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone.J Trauma. 1994 May;36(5):726-33. doi: 10.1097/00005373-199405000-00022. J Trauma. 1994. PMID: 8189476 Clinical Trial.
-
Integrated nutritional, hormonal, and metabolic effects of recombinant human growth hormone (rhGH) supplementation in trauma patients.Nutrition. 1996 Nov-Dec;12(11-12):777-87. doi: 10.1016/s0899-9007(96)00220-1. Nutrition. 1996. PMID: 8974104 Clinical Trial.
-
Adjuvant recombinant human growth hormone does not augment endogenous glucose production in total parenteral nutrition-fed multiple trauma patients.Metabolism. 1996 Apr;45(4):450-6. doi: 10.1016/s0026-0495(96)90218-8. Metabolism. 1996. PMID: 8609830 Clinical Trial.
-
Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study.Crit Care Med. 1996 Mar;24(3):403-13. doi: 10.1097/00003246-199603000-00008. Crit Care Med. 1996. PMID: 8625627 Review.
-
Effect of administered human growth hormone on protein metabolism in septic rats.JPEN J Parenter Enteral Nutr. 1989 Sep-Oct;13(5):450-4. doi: 10.1177/0148607189013005450. JPEN J Parenter Enteral Nutr. 1989. PMID: 2514284 Review.
Cited by
-
Interventions for preventing critical illness polyneuropathy and critical illness myopathy.Cochrane Database Syst Rev. 2014 Jan 30;2014(1):CD006832. doi: 10.1002/14651858.CD006832.pub3. Cochrane Database Syst Rev. 2014. PMID: 24477672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources